About F4 Pharma
F4 Pharma is a company based in Vienna (Austria) founded in 2013. F4 Pharma offers products and services including FX06. F4 Pharma operates in a competitive market with competitors including Basking Biosciences, Acticor Biotech, 4TEEN4 Pharmaceuticals, AptaTargets and CeleCor Therapeutics, among others.
- Headquarter Vienna, Austria
- SectorsHealthcare
- Website f4-pharma.com
- Legal Name F4 Pharma Gmbh
- Latest Funding Round$3.11M (USD), Grant
Aug 2021
- Investors
Products & Services of F4 Pharma
F4 Pharma offers a comprehensive portfolio of products and services, including FX06.
Inhibits inflammatory reactions and prevents capillary leak in diseases.
Funding Insights of F4 Pharma
- Total Rounds 1
- Last Round Grant — $3.11M
- First Round $3.11M
(Aug 2021)
- Investors Count 1
All 1 funding rounds of F4 Pharma with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2021 | $3.11M | Grant | – | – |
1 investors in total: 1 institutional.
Investors in F4 Pharma
F4 Pharma has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium |
Investor details for F4 Pharma
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of F4 Pharma
2 dated milestones of F4 Pharma across 8 years, from founding to its latest funding, stage changes and deals.
- Founded F4 Pharma is founded.
- Funding First funding round of $3.1M.
Competitors of F4 Pharma
F4 Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Basking Biosciences, Acticor Biotech, 4TEEN4 Pharmaceuticals, AptaTargets and CeleCor Therapeutics, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| baskingbiosciences.com | 2019 | Columbus, United States | $89.8M | 3 | Therapeutics for ischemic stroke treatment are developed. | |
| acticor-biotech.com | 2013 | Paris, France | $31.36M | – | Immunotherapeutics are developed for ischemic stroke treatment using monoclonal antibodies. | |
| 4teen4.de | 2013 | Hennigsdorf, Germany | $30.68M | – | Therapeutics and diagnostics for cardiovascular diseases are developed. | |
| aptatargets.com | 2014 | Madrid, Spain | $2.98M | – | Provider of therapeutic solutions for ischemic diseases | |
| celecor.com | 2017 | San Diego, United States | $46.5M | – | POC subcutaneous injectable for myocardial infarction treatment is developed. | |
| tsillc.net | 2006 | Cambridge, United States | $7.5M | 6 | Clot-dissolving therapies using mutant prounokinase are developed for thrombotic diseases. | |
| infensabioscience.com | 2021 | Sydney, Australia | $15.6M | – | Peptide drugs for cardiovascular disorders are developed. | |
| endoprotech.com | 2005 | Louisville, United States | – | – | Liposome-based therapies are developed for myocardial infarction and liver disease. | |
| decktherapeutics.com | 2019 | Albany, United States | – | – | Drugs for traumatic brain injury and stroke are developed. |
Detailed competitors of F4 Pharma
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on F4 Pharma
Complete news archive for F4 Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to F4 Pharma
10 companies that operate in the same segment as F4 Pharma (Cardiac and Vascular Disorders), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Connected devices for health, sleep, and activity monitoring are developed. | 2008 | Moulineaux, Seine-maritime, France | USD 93.83 M | – | – | |
SMT is recognized as a developer of cardiovascular medical devices. | 1998 | Surat, Gujarat, India | USD 57.22 M | USD 106.25 M | 1,090 | |
Gene-editing therapies for coronary artery disease are developed. | 2018 | Cambridge, Massachusetts, United States | USD 215.5 M | – | 255 | |
Cardiac monitoring devices and applications are provided for heart health. | 2010 | Mountain View, California, United States | USD 114.38 M | USD 6.18 M | 67 | |
Therapies for lowering low-density lipoprotein cholesterol levels are developed. | 1998 | Ann Arbor, Michigan, United States | USD 129.7 M | USD 332.31 M | 304 | |
Cloud-based ambulatory ECG monitors for cardiac arrhythmia diagnosis are provided. | 2006 | San Francisco, California, United States | USD 109.23 M | USD 747.14 M | 2,000 | |
Provider of neuroprotection devices for carotid artery disease | 2007 | Sunnyvale, California, United States | USD 241.8 M | – | – | |
Miniaturized wireless implantable sensors are developed for hemodynamic monitoring. | 2007 | East Peoria, Illinois, United States | USD 154.77 M | – | 104 | |
Access catheters for neurovascular stroke treatment are provided. | 2015 | Campbell, California, United States | USD 596 M | – | – | |
Biosensor patches are developed for monitoring multiple body vitals. | 2011 | Campbell, California, United States | USD 239.95 M | – | 184 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about F4 Pharma
F4 Pharma was founded in 2013 and raised its 1st funding round 8 years after it was founded.
F4 Pharma is headquartered in Vienna, Austria.
F4 Pharma was founded in 2013 in Vienna, Austria, where operations in the pharmaceutical sector are based. Focus is placed on the development and production of drugs targeted at preventing reperfusion injury following myocardial infarction. Activities encompass research, manufacturing, and distribution within the biotechnology and cardiovascular fields, with primary facilities located in Austria to support clinical and therapeutic advancements.
F4 Pharma's top competitors include Acticor Biotech, 4TEEN4 Pharmaceuticals and Basking Biosciences.
F4 Pharma offers FX06.
F4 Pharma has 1 investor. Key investors include European Union.
F4 Pharma operates through F4 Pharma Gmbh.